Enlivex Therapeutics Ltd.

ENLV · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,301$813$47,822$11,202
Short-Term Investments$20,195$26,507$299$72,928
Receivables$1,302$0$0$1,087
Inventory$0$0$1,177-$12,203
Other Curr. Assets$1,082$6,215$1,439$2,312
Total Curr. Assets$25,993$33,764$52,330$86,442
Property Plant & Equip (Net)$1,153$2,580$14,900$8,219
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$531$308$307$3
Tax Assets$0$0$0$0
Other NC Assets$10$179$105$482
Total NC Assets$1,694$3,067$15,312$8,704
Other Assets$0$0$0$0
Total Assets$27,687$36,831$67,642$95,146
Liabilities
Payables$811$827$1,948$878
Short-Term Debt$470$346$653$617
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,518$4,888$4,006$3,223
Total Curr. Liab.$3,799$6,061$6,607$4,718
LT Debt$299$686$4,194$5,389
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$299$686$4,194$5,389
Other Liabilities$0$0$0$0
Cap. Leases$534$1,032$4,847$6,006
Total Liabilities$4,098$6,747$10,801$10,107
Equity
Pref Stock$0$0$0$0
Common Stock$2,685$2,137$2,117$2,107
Retained Earnings-$127,107-$112,093-$83,025-$51,965
AOCI$1,101$1,101$1,101$1,101
Other Equity$146,910$138,939$136,648$133,796
Total Equity$23,589$30,084$56,841$85,039
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$27,687$36,831$67,642$95,146
Net Debt-$2,532$219-$42,975-$5,196